Operator and Intraprocedural Strategies to Reduce Contrast-Induced Acute Kidney Injury

Sanjog Kalra,Ziad Anwar Ali,Dimitri Karmpaliotis,Ajay J. Kirtane,Jeffrey W. Moses

DOI: https://doi.org/10.1007/978-3-030-45414-2_14

2020-01-01

Abstract:Contrast-induced acute kidney injury (CI-AKI) represents a major adverse outcome associated with percutaneous coronary interventions, especially in patients with underlying chronic kidney disease (CKD). The elevated risk for future CKD and its attendant cardiovascular disease burden with severe or repeated episodes of CI-AKI is well established. However, the concern for CI-AKI is also a major reason that patients with CKD are not referred for revascularization, even when appropriate and clinically indcated. Careful periprocedural optimization of hemodynamics, medications, and cardiorenal interdisciplinary planning can have a major impact on reduction of CI-AKI burden and are described in this chapter. Additionally, several novel intraprocedural techniques have emerged within the last decade that allow optimal revascularization to be achieved in patients with advanced CKD with minimal impact on renal function. Given the known exclusion of patients with CKD from targeted therapies (both medical and procedural), integrating best clinical practices and expanding the use of state-of-the-art procedural techniques such as “zero contrast PCI” can reduce this disparity and facilitate reductions in morbidity and mortality associated with ischemic heart disease in this vulnerable population.